MOTS-c vs PT-141: What Is the Difference?
One was found inside mitochondrial DNA. The other was found by accident while researching suntans. Both need to stay in the dark.
In plain English
MOTS-c is a sixteen-amino-acid molecule encoded inside mitochondrial DNA, studied as a signal that the cell's power plants send out about their energy status.
PT-141 is a small ring-shaped molecule, a breakdown product of a compound developed for skin pigmentation research, redirected after an unexpected observation.
The difference, without the jargon
Two very different discovery stories with one thing in common. MOTS-c was found by looking somewhere nobody expected to find a signalling molecule — inside the mitochondrial genome, which was assumed to encode only energy machinery. PT-141 was found sideways, as a metabolite of a pigmentation compound that produced an unanticipated result. Their research areas are unrelated: cellular energy sensing versus melanocortin receptors and central nervous system effects. What they share is tryptophan, the amino acid most easily damaged by light, so both need genuine darkness and both yellow as they degrade. MOTS-c is the fussier of the two because it also carries methionine, which reacts with oxygen, giving it two vulnerabilities instead of one.
Common questions
What is the difference between MOTS-c and PT-141?
MOTS-c is encoded in mitochondrial DNA and studied around cellular energy signalling. PT-141 acts on melanocortin receptors and is studied for central nervous system effects. Unrelated research areas with very different origins.
Why do both need dark storage?
Both contain tryptophan, the most light-sensitive amino acid. Light damage shows up as yellowing of what should be white powder, which is a reason to discard the vial.
Which is more sensitive?
MOTS-c. Alongside tryptophan it also contains methionine, which reacts with oxygen, so it needs both darkness and minimal air exposure. PT-141 mainly needs darkness.
Technical reference below
How they actually differ
Comparing the two: MOTS-C is mitochondrial-derived peptide, 16 residues, while PT-141 (Bremelanotide) is cyclic heptapeptide, melanocortin receptor agonist — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (methionine oxidation to the sulfoxide (+16 da), and mots-c carries methionine at the n-terminus and internally. for MOTS-C, tryptophan photo-oxidation for PT-141 (Bremelanotide)), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
MOTS-C — origin
MOTS-c is encoded not in nuclear DNA but within the mitochondrial genome — specifically an open reading frame inside the 12S ribosomal RNA gene. Its discovery helped establish that mitochondria encode short signalling peptides that act on the rest of the cell, a genuinely recent addition to cell biology and the reason the compound attracted rapid research interest.
PT-141 (Bremelanotide) — origin
PT-141 is a metabolite of Melanotan II, and its history is an unusually direct case of a side effect becoming the research programme. Melanotan II was developed as a synthetic α-MSH analogue for pigmentation research; an unanticipated effect observed during that work redirected attention to the metabolite, which was then developed separately as bremelanotide.
MOTS-C research themes
Part of a novel class demonstrating that mitochondria encode peptides acting systemically.
The most-studied signalling interaction, examined in metabolic and exercise models.
Investigated in glucose-metabolism research models.
Studies have examined MOTS-c expression in relation to physical activity and ageing in animal models.
PT-141 (Bremelanotide) research themes
Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.
Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.
Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.
The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.
MOTS-C handling
- Use amber vials or wrap in foil; treat light protection as mandatory rather than precautionary.
- Minimise vial openings — headspace oxygen is the practical driver of oxidation.
- Use low-bind labware for dilute working solutions.
PT-141 (Bremelanotide) handling
- Protect from light at all stages.
- Standard gentle reconstitution; the constrained ring is not agitation-sensitive in the way flexible long chains are.
- Store refrigerated and aliquot rather than repeatedly sampling one vial.
Both third-party tested
Every Popular Peptides batch of MOTS-C and PT-141 (Bremelanotide) is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
MOTS-C reference
Related comparisons
MOTS-C and PT-141 (Bremelanotide) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.